Effect of Ciprofibrate on Platelet Aggregation and Fibrinolysis in Patients with Hypercholesterolaemia
1985 ◽
Vol 54
(02)
◽
pp. 442-444
◽
Keyword(s):
SummaryThe fibrinolytic and platelet effects of Ciprofibrate, a new lipid lowering drug, were studied in 7 patients with hypercholesterolaemia over a 12 week period. A significant reduction in plasma fibrinogen was noted and a lesser increase in fibrinolytic activity. However, no change in platelet aggregation was noted. As expected Ciprofibrate produced a significant hypolipidaemic effect in these patients.We have described effects of Ciprofibrate which may have potential benefits in this high risk patient group.
Keyword(s):
2008 ◽
Vol 15
(2)
◽
pp. 102-107
◽
Keyword(s):
2020 ◽
Vol 20
(28)
◽
pp. 2634-2647
Keyword(s):
2021 ◽
Vol 16
(2)
◽
pp. 16-24
2017 ◽
Vol 263
◽
pp. e236-e237
◽
Keyword(s):
2000 ◽
Vol 36
(5)
◽
pp. 1572-1578
◽
2013 ◽
Vol 11
(30)
◽
pp. 4993
◽
Keyword(s):